Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cellomics Technology
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cellomics Technology

Cellomics Technology

Seed

Cellomics Technology LLC: A biotech firm specializing in lentivirus production and gene manipulation.

HQ
Baltimore, MD, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to advance gene engineering, Cellomics Technology LLC is a biotechnology company specializing in lentivirus production, gene targeting, stable cell line generation, gene cloning, and DNA mutagenesis. The company is dedicated to developing innovative tools for mammalian cell gene engineering, including gene knockout, knockdown, and overexpression. Their products and custom services cater to both somatic and stem cell genetic engineering, aiming to accelerate research in these fields.

Cellomics Technology has garnered attention for its scientific excellence and impactful contributions to biotechnology. The company collaborates with leading researchers and institutions to push the boundaries of genetic engineering. Notable achievements include the development of highly effective lentiviral vectors for gene delivery into hard-to-transfect cells like T cells and neurons. Through these advancements, Cellomics Technology is significantly impacting the field of genetic research and therapy.

Cellomics Technology - Similar Companies

ExpressCells logo

ExpressCells

OpenCell Technologies logo

OpenCell Technologies

Celldom logo

Celldom

celldom.com

Vector Biomed logo

Vector Biomed

vectorbiomed.com

Celltheon logo

Celltheon

celltheon.com

PackGene Biotech logo

PackGene Biotech

packgene.com

Cellular Engineering Technologies logo

Cellular Engineering Technologies

celleng-tech.com

Cellino logo

Cellino

cellinobio.com

Cellanome logo

Cellanome

cellanome.com

CellFE logo

CellFE

Cell Microsystems logo

Cell Microsystems

Transomic Technologies logo

Transomic Technologies

Xcell Biosciences logo

Xcell Biosciences

xcellbio.com

GeneExcel logo

GeneExcel

MultiCell Technologies logo

MultiCell Technologies

Cellomics Technology - Quick Facts

Who are Cellomics Technology's competitors?

Companies similar to Cellomics Technology include ExpressCells, OpenCell Technologies, Celldom and Vector Biomed.

When was Cellomics Technology founded?

Cellomics Technology was founded in 2011.

Where is Cellomics Technology's headquarters located?

Cellomics Technology's headquarters is located in Baltimore, MD, US.

When was Cellomics Technology's last funding round?

Cellomics Technology's most recent funding round was for $150k (USD) in April 2012.

How much has Cellomics Technology raised to-date?

As of Apr 12, 2012, Cellomics Technology has raised a total of $150k (USD).

How many employees does Cellomics Technology have?

Cellomics Technology has 3 employees as of Feb 5, 2024.

Cellomics Technology - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Services
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Gene Editing
  • Lentivirus Production
Tags
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified